The common adverse effects of Remdesivir in severely infected COVID-19 patients have included nausea, acute respiratory failure, increased alanine aminotransferase (ALT) and constipation [39], and liver toxicity linked to tocilizumab [6]. The gene discussed is GPT; the disease is acute respiratory failure.